GlassScriptPhysician profile
Yazmin Enchautegui Colon
NPI 1770900904
$525.55
in general payments reported to CMS, 2019-2025
8 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Clinical Genetics (M.D.) provider received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.00 · 2023: $132 · 2024: $60.39 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $163.88 | 2025 | |
| Alexion Pharmaceuticals, INC. | $148.86 | 2023-2025 | Koselugo, Strensiq |
| Takeda Pharmaceuticals U.S.A., INC. | $55.74 | 2023-2024 | Vpriv, Elaprase |
| Ultragenyx Pharmaceutical INC. | $45.11 | 2021-2025 | Dojolvi |
| Medunik USA INC. | $39.29 | 2024-2025 | Pheburane |
| Ptc Therapeutics, INC. | $31.60 | 2025 | Sephience |
| Amicus Therapeutics, INC. | $21.44 | 2025 | |
| Cycle Pharmaceuticals INC | $19.63 | 2025 | Javygtor, Nityr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yazmin Enchautegui Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.